Patents by Inventor Lars Anders

Lars Anders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR AND A CDK4 INHIBITOR FOR TREATING CANCER
    Publication number: 20250041277
    Abstract: This disclosure relates to combination therapies for use in treating cancer, comprising a CDK2 inhibitor of Formula (I) and a selective CDK4 inhibitor of Formula (II), each as further described herein, optionally in further combination with an additional anti-cancer agent.
    Type: Application
    Filed: December 1, 2022
    Publication date: February 6, 2025
    Applicant: PFIZER INC.
    Inventors: Lars ANDERS, Jerry LI, Tun Tun LIN, Ping WEI, Jing YANG, Todd Lee VANARSDALE
  • COMBINATION THERAPY
    Publication number: 20240000783
    Abstract: This invention relates to combination therapies comprising a cyclin dependent kinase 4 (CDK4) inhibitor of Formula (I) or a pharmaceutically acceptable salt thereof, and an antiandrogen, optionally in further combination with an additional anti-cancer agent, and associated methods of treatment, pharmaceutical compositions, and uses thereof.
    Type: Application
    Filed: August 10, 2021
    Publication date: January 4, 2024
    Applicants: Pfizer Inc., Astellas Pharma Inc.
    Inventors: Lars ANDERS, Kimberly Hyunjung KIM, Danan LI, Elizabeth Anne MCMILLAN, Robert Andrew ROLLINS, Brendan Ayers VEENEMAN
  • COMBINATION OF A CYCLIN DEPENDENT KINASE INHIBITOR AND A BET- BROMODOMAIN INHIBITOR
    Publication number: 20200405809
    Abstract: This invention relates to combination therapies comprising a cyclin dependent kinase (CDK) inhibitor that inhibits CDK4 and/or CDK6, and a bromodomain and extra-terminal domain (BET) family inhibitor, and associated pharmaceutical compositions, methods of treatment, and pharmaceutical uses.
    Type: Application
    Filed: February 22, 2019
    Publication date: December 31, 2020
    Applicant: Pfizer Inc.
    Inventors: Lars Anders, Danan Li
  • Genome-wide Method of Assessing Interactions Between Chemical Entities And Their Target Molecules
    Publication number: 20150167062
    Abstract: The invention is directed to a method of mapping, across a genome, interaction of a drug with one or more factors that associate with the genome.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 18, 2015
    Inventors: Richard A. Young, James E. Bradner, Peter B. Rahl, Lars Anders, Jason J. Marineau, Jun Qi, Matthew G. Guenther